Top Big Cap Negative News Movers Premarket: VKTX: -13% Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes MGM: -10% People Withdraws Buyout Proposal GRAL: -9% FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test ACAD: -7% Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin HAFN: -7% Completion and Pricing of Placement of Ordinary Shares SNX: -6% Earnings BE: -6% Sympathy to ORCL Headlin
Top Big Cap Negative News Movers Premarket: VKTX: -13% Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes MGM: -10% People Withdraws Buyout Proposal GRAL: -9% FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test ACAD: -7% Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin HAFN: -7% Completion and Pricing of Placement of Ordinary Shares SNX: -6% Earnings BE: -6% Sympathy to ORCL Headlines FSLY: -5% Insider Sales ORCL: -4% ORACLE SENDS FORCE MAJEURE NOTICE OVER NEW MEXICO DATA CENTER DRI: -3% Earnings CRDO: -3% Insider Sales
Top Big Cap Negative News Movers Premarket: VKTX: -13% Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes MGM: -10% People Withdraws Buyout Proposal GRAL: -9% FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test ACAD: -7% Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin HAFN: -7% Completion and Pricing of Placement of Ordinary Shares SNX: -6% Earnings BE: -6% Sympathy to ORCL Headlines FSLY: -5% Insider Sales ORCL: -4% ORACLE SENDS FORCE MAJEURE NOTICE OVER NEW MEXICO DATA CENTER DRI: -3% Earnings CRDO: -3% Insider Sales